{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:40:37Z","timestamp":1781264437240,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1331\/japha.2015.14114","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T20:30:19Z","timestamp":1423254619000},"page":"193-197","source":"Crossref","is-referenced-by-count":7,"title":["Iatrogenic Cushing's syndrome after triamcinolone plus ritonavir-boosted atazanavir"],"prefix":"10.1016","volume":"55","author":[{"given":"Bernadette","family":"Jakeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bouchonville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2015.14114_bb0010","series-title":"Norvir (ritonavir) oral tablets [product labeling]","year":"2013"},{"key":"10.1331\/JAPhA.2015.14114_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40291-013-0028-5","article-title":"Applications of CYP450 testing in the clinical setting","volume":"17","author":"Samer","year":"2013","journal-title":"Mol Diagn Ther"},{"key":"10.1331\/JAPhA.2015.14114_bb0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.qai.0000187444.38461.70","article-title":"Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers","volume":"40","author":"Penzak","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1331\/JAPhA.2015.14114_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1468-1293.2008.00579.x","article-title":"Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature","volume":"9","author":"Foisy","year":"2008","journal-title":"HIV Med"},{"key":"10.1331\/JAPhA.2015.14114_bb0030","first-page":"779","article-title":"Cushing's syndrome induced by combined treatment with inhaled fluticasone and oral ritonavir","volume":"7","author":"Dupont","year":"2009","journal-title":"Case Rep"},{"key":"10.1331\/JAPhA.2015.14114_bb0035","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1503\/cmaj.111315","article-title":"Cushing syndrome due to ritonavir-fluticasone interaction","volume":"184","author":"Canalejo","year":"2012","journal-title":"CMAJ"},{"key":"10.1331\/JAPhA.2015.14114_bb0040","first-page":"830","article-title":"Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient","volume":"47","author":"Kedem","year":"2010","journal-title":"Case Rep"},{"key":"10.1331\/JAPhA.2015.14114_bb0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1331\/JAPhA.2015.14114_bb0050","series-title":"Kenolog (triamcinolone acetonide)-10 Injection [product labeling]","year":"2014"},{"key":"10.1331\/JAPhA.2015.14114_bb0055","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/j.1552-4604.1994.tb02051.x","article-title":"Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide","volume":"34","author":"Argenti","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"10.1331\/JAPhA.2015.14114_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/clpt.1986.45","article-title":"Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration","volume":"39","author":"Derendorf","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1331\/JAPhA.2015.14114_bb0065","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1086\/593314","article-title":"Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir","volume":"47","author":"Ramanathan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1331\/JAPhA.2015.14114_bb0070","doi-asserted-by":"crossref","first-page":"849432","DOI":"10.1155\/2014\/849432","article-title":"Iatrogenic Cushing syndrome secondary to ritonavir-epidural triamcinolone interaction: an illustrative case and review","volume":"2014","author":"Sadarangani","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1331\/JAPhA.2015.14114_bb0075","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0000000000000010","article-title":"Pulmonary embolism and iatrogenic Cushing's syndrome after co-administration of injected triamcinolone and ritonavir","volume":"27","author":"John","year":"2013","journal-title":"AIDS"},{"key":"10.1331\/JAPhA.2015.14114_bb0080","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0956462413480723","article-title":"Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir","volume":"24","author":"Hall","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1331\/JAPhA.2015.14114_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s15010-013-0506-z","article-title":"Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature","volume":"41","author":"Schwarze Zander","year":"2013","journal-title":"Infection"},{"key":"10.1331\/JAPhA.2015.14114_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00256-012-1539-6","article-title":"Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing's syndrome","volume":"42","author":"Maviki","year":"2013","journal-title":"Skeletal Radiol"},{"key":"10.1331\/JAPhA.2015.14114_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MAJ.0b013e31824ceb2b","article-title":"Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome","volume":"344","author":"Albert","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1331\/JAPhA.2015.14114_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pmrj.2011.10.003","article-title":"Iatrogenic Cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIV-infected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists","volume":"4","author":"Grierson","year":"2012","journal-title":"PM R"},{"key":"10.1331\/JAPhA.2015.14114_bb0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.36076\/ppj.2012\/15\/489","article-title":"Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors","volume":"15","author":"Fessler","year":"2012","journal-title":"Pain Physician"},{"key":"10.1331\/JAPhA.2015.14114_bb0110","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaad.2010.09.014","article-title":"Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy","volume":"65","author":"Levine","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1331\/JAPhA.2015.14114_bb0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.5435\/00124635-200910000-00006","article-title":"The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level 1 studies","volume":"17","author":"Hepper","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1331\/JAPhA.2015.14114_bb0120","first-page":"CD005328","article-title":"Intraarticular corticosteroid for treatment of osteoarthritis of the knee","volume":"2","author":"Bellamy","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1331\/JAPhA.2015.14114_bb0125","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf Accessed September 15, 2014; 2014: F-2."},{"key":"10.1331\/JAPhA.2015.14114_bb0130","unstructured":"Stribild (elvitegravir\/cobicistat\/emtricitabine\/tenofovir) oral tablets[product labeling]. Gilead Sciences, Inc., Foster City, CA, USA, 2013. http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/hiv\/stribild\/stribild_pi.pdf. Accessed July 16, 2014."},{"key":"10.1331\/JAPhA.2015.14114_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QAI.0b013e31817bebeb","article-title":"Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals","volume":"48","author":"Busse","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1331\/JAPhA.2015.14114_bb0140","series-title":"Sustiva oral capsules and tablets [product labeling]","year":"2013"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911530042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911530042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T20:13:28Z","timestamp":1651176808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431911530042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S154431911530042X"],"URL":"https:\/\/doi.org\/10.1331\/japha.2015.14114","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}